ストックスクリーナーアプリを入手
14.81
1.66%
-0.25
アフターアワーズ：
14.81
Jade Biosciences Inc (JBIO) 最新ニュース
Weekly Earnings: Is Jade Biosciences Inc a speculative investmentJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Shares Gap UpHere's Why - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update - MarketBeat
Aug Sentiment: Is Jade Biosciences Inc a speculative investment2025 Top Gainers & Long-Term Investment Growth Plans - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Trading Up 8.1%What's Next? - MarketBeat
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN
Jade Biosciences (NASDAQ:JBIO) Stock Price Down 5.3%Here's What Happened - MarketBeat
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock - MSN
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue - Finviz
Short Interest in Jade Biosciences, Inc. (NASDAQ:JBIO) Increases By 47.9% - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Breakout Watch: What is AvePoint Incs TAM Total Addressable MarketMarket Trend Report & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
JBIO: Advancing novel autoimmune therapies with strong data, market potential, and rapid clinical timelines - TradingView
Valuation Update: What is the PEG ratio of Jade Biosciences IncJuly 2025 PostEarnings & AI Enhanced Trading Alerts - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Trading Down 4.8%Should You Sell? - MarketBeat
Published on: 2026-01-10 20:20:04 - ulpravda.ru
How risky is Jade Biosciences Inc. stock nowPortfolio Profit Report & Fast Entry and Exit Trade Plans - Улправда
Will Jade Biosciences Inc. stock rally after Fed decisionsJuly 2025 Final Week & Real-Time Chart Pattern Alerts - Улправда
How Jade Biosciences Inc. stock reacts to global recession fearsFit and Size Notes & quick comparison of popular models - Улправда
Equities Analysts Offer Predictions for JBIO FY2025 Earnings - MarketBeat
How Jade Biosciences Inc. stock reacts to job market dataJuly 2025 Breakouts & Accurate Entry and Exit Point Alerts - Улправда
Jade Biosciences (NASDAQ:JBIO) Coverage Initiated at HC Wainwright - Defense World
Why Jade Biosciences Inc. stock is popular among millennialsQuarterly Portfolio Review & Daily Growth Stock Tips - Улправда
Will Jade Biosciences Inc. stock benefit from sector rotationPortfolio Performance Summary & Stepwise Trade Signal Implementation - Улправда
Why Jade Biosciences Inc. stock remains a top recommendationMarket Activity Report & Expert Approved Momentum Ideas - Улправда
Jade Biosciences (NASDAQ:JBIO) Upgraded to Strong-Buy at HC Wainwright - MarketBeat
H.C. Wainwright initiates coverage on Jade Biosciences stock with Buy rating - Investing.com India
This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq
Institutional Investors of Jade Biosciences, Inc. (NASDAQ:JBIO) Must Be Disappointed After Last Week's 16% Drop - 富途牛牛
Does Jade Biosciences, Inc. (JBIO) have the potential to rally 65% as Wall Street analysts expect? - MSN
The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares - simplywall.st
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance
Jade Biosciences outlines 2026 clinical pipeline and milestones By Investing.com - Investing.com Nigeria
Jade Biosciences (NASDAQ:JBIO) Shares Gap DownTime to Sell? - MarketBeat
Jade Biosciences Outlines 2026 Autoimmune Pipeline Priorities - TipRanks
Jade Biosciences outlines 2026 clinical pipeline and milestones - Investing.com
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Jade Biosciences (NASDAQ:JBIO) Trading Down 3.7%Here's Why - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5%Here's What Happened - MarketBeat
Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating - MarketScreener
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Volume Report: Why Jade Biosciences Inc stock is popular among millennials2025 Technical Patterns & Daily Growth Stock Tips - moha.gov.vn
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):